1
|
Dooley J, Ghezal A, Gilpin T, Hassan Basri H, Humberstone K, Lahdelma A, Misurya P, Marshall E, Watkins E. Assessing the impact of university students' involvement in the first year of Nurture-U: a national student wellbeing research project. RESEARCH INVOLVEMENT AND ENGAGEMENT 2023; 9:95. [PMID: 37848961 PMCID: PMC10580553 DOI: 10.1186/s40900-023-00478-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Accepted: 07/28/2023] [Indexed: 10/19/2023]
Abstract
BACKGROUND Students experience lower levels of wellbeing than the general, age-matched population. A whole-university approach to mental health is encouraged, which must work for individuals from all backgrounds and experiences. Student input is vital in researching and designing these solutions. Nurture-U is a national, large-scale research project exploring better ways to support student wellbeing, with a Student Advisory Group (SAG) that feeds into project decision making. With the first year of the project now completed, we now critically review the processes and effectiveness of the SAG and how well the project is engaging and working with students. METHODS Assessment of the SAG's impact on the project, the student advisors, and the researchers was undertaken through a content analysis of team meetings and collection of advisor and researcher feedback using the Patient Engagement Quality Guidance Tool. RESULTS 142 students worked on different tasks in the first year of the Nurture-U project. The SAG was involved in the project branding and marketing, and in the development and co-design of interventions and tools. They reported a positive experience, with involvement boosting confidence. They felt valued but reported not always knowing whether their input was implemented in final decisions. They also recommended different methods of providing feedback. Researchers found student input beneficial to communicate the viewpoint of a different generation and increase the relevance of the study, but also suggested improvements for communication between the research team and the student group. CONCLUSIONS This critical reflection of the SAG's public advisor role in this large-scale research project was important in highlighting what worked well and areas to improve. As the project unfolds, we aim to adapt our methods of student input, increase the transparency of decision-making processes, and in turn increase student-led decision making within the project.
Collapse
Affiliation(s)
- Jemima Dooley
- Sir Henry Wellcome Centre for Mood Disorders Research, University of Exeter, Devon, EX4 4QG, UK.
| | - Amina Ghezal
- Department of Politics, University of Exeter, Penryn, Cornwall, TR10 9FE, UK
| | - Thomas Gilpin
- Coronary Research Group, University Hospital Southampton, Southampton, SO16 6YD, UK
- Faculty of Medicine, University of Southampton, Southampton, SO17 1BJ, UK
| | | | - Katy Humberstone
- Department of Languages, Cultures and Visual Studies, University of Exeter, Devon, EX4 4QH, UK
- Department of Languages, Cultures and Linguistics, University of Southampton, Hampshire, SO17 1BF, UK
| | - Amber Lahdelma
- Combined Honours Department, Peter Chalk, University of Exeter, Devon, EX4 4QD, UK
| | - Pranati Misurya
- Department of Psychology, University of Exeter, Devon, EX44QG, UK
| | - Ellen Marshall
- School of Psychology, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK
| | - Ed Watkins
- Sir Henry Wellcome Centre for Mood Disorders Research, University of Exeter, Devon, EX4 4QG, UK
| |
Collapse
|
2
|
Jørgensen K, Hansen M, Andersen TG, Hansen M, Karlsson B. Healthcare Professionals' Experiences with Patient Participation in a Mental Healthcare Centre: A Qualitative Study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:1965. [PMID: 36767331 PMCID: PMC9916001 DOI: 10.3390/ijerph20031965] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2022] [Revised: 01/17/2023] [Accepted: 01/18/2023] [Indexed: 06/18/2023]
Abstract
INTRODUCTION Patient participation is a cornerstone of the debate concerning healthcare professionals and patients of mental health centres. It constitutes an objective in government health policy in Scandinavia and other Western countries. However, little is known about the experiences of healthcare professionals in mental healthcare practices involving patients under their treatment and care. OBJECTIVE This study aimed to explore the experiences of healthcare professionals with patient participation in the context of a mental health centre. METHODOLOGICAL DESIGN Four focus group interviews with healthcare professionals reflected differing experiences with unfolding patient participation in clinical practices in four wards of a mental health centre. A content analysis developed and framed themes. RESULTS Patient participation was based on structural conditions, which shows that predetermined structural methods predominantly control involvement. The structural methods are seen as promoting participation from the patient's perspective. At the same time, the methods also enable taking account of the individual patient's wishes and needs for involvement. DISCUSSION AND CONCLUSION This study illuminates the meaning of patient participation in a mental health centre based on the social interactions among nurses and other healthcare professionals. The approach can contribute to dealing with the challenges of incorporating patient participation as an ideology for all patients in a psychiatric context, which is important knowledge for healthcare professionals.
Collapse
Affiliation(s)
- Kim Jørgensen
- Department of Public Health, Nursing, Aarhus University, 8000 Aarhus C, Denmark
| | - Mathias Hansen
- University College Diaconissestiftelsen, 2000 Frederiksberg, Denmark
| | | | - Morten Hansen
- Psychiatric Outpatient Clinic Ishøj, Bostedsteamet, 2635 Ishøj, Denmark
| | - Bengt Karlsson
- Centre for Mental Health and Substance Abuse, Department of Health, Social and Welfare Studies, Faculty of Health and Social Sciences, University of Southeastern Norway, P.O. Box 7053, 3007 Drammen, Norway
| |
Collapse
|
3
|
Cui W, Phillips KA, Anderson RA, Francis PA, Loi S, Loibl S, Partridge AH, Keogh LA. Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholders. Am J Cancer Res 2022; 12:5599-5612. [PMID: 36628283 PMCID: PMC9827081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Accepted: 11/27/2022] [Indexed: 01/12/2023] Open
Abstract
Clinical trial endpoints are fundamental for evaluating the safety and efficacy of cancer therapies, yet it is not well understood how they are selected or the role of stakeholder groups in deciding endpoints. This study aimed to explore how clinical trial endpoints are selected in breast cancer trials of anti-cancer drugs through semi structured interviews with purposively selected stakeholders involved in breast cancer clinical trials (clinicians, consumers, pharmaceutical company representatives, and members of drug regulatory agencies). Participants were asked to describe the process of selecting trial endpoints. Interviews were transcribed verbatim and analysed using inductive thematic analysis supported by NVivo software. Saturation of the main themes was reached and the final sample included 25 participants from 14 countries (9 clinicians, 7 consumers, 5 members of regulatory agencies, 4 pharmaceutical company representatives). Pharmaceutical companies were almost always identified as the main decision maker. While most consumers and pharmaceutical company representatives felt clinicians and consumers influenced trial design, some clinicians and regulators reported consumers and clinicians had little influence. Factors identified as important considerations in determining trial endpoints included the main goal of the trial, established standardised endpoints, resources, and the investigational agent studied. All pharmaceutical advisors reported that meeting the requirements for regulatory approval was the major factor considered. Clinical trial endpoint selection is largely decided by the pharmaceutical industry, driven by requirements for regulatory approval. Given the limited influence from clinicians and consumers, guidance by regulatory agencies will be important for future inclusion of novel endpoints in clinical trials.
Collapse
Affiliation(s)
- Wanyuan Cui
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne305 Grattan Street, Melbourne 3000, VIC, Australia,Department of Medical Oncology, Peter MacCallum Cancer Centre305 Grattan Street, Melbourne 3000, VIC, Australia
| | - Kelly-Anne Phillips
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne305 Grattan Street, Melbourne 3000, VIC, Australia,Department of Medical Oncology, Peter MacCallum Cancer Centre305 Grattan Street, Melbourne 3000, VIC, Australia,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of MelbourneMelbourne, VIC, Australia
| | - Richard A Anderson
- MRC Centre for Reproductive Health, University of Edinburgh47 Little France Crescent Edinburgh EH16 4TJ, UK
| | - Prudence A Francis
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne305 Grattan Street, Melbourne 3000, VIC, Australia,Department of Medical Oncology, Peter MacCallum Cancer Centre305 Grattan Street, Melbourne 3000, VIC, Australia
| | - Sherene Loi
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne305 Grattan Street, Melbourne 3000, VIC, Australia,Department of Medical Oncology, Peter MacCallum Cancer Centre305 Grattan Street, Melbourne 3000, VIC, Australia,Division of Research, Peter MacCallum Cancer Centre305 Grattan Street, Melbourne 3000, VIC, Australia
| | - Sibylle Loibl
- German Breast GroupMartin Behaim Strasse 12, Neu-Isenburg 63263, Germany,Centre for Haematology and OncologyBethanien, Im Prüfling 17, Frankfurt 60389, Germany
| | - Ann H Partridge
- Department of Medical Oncology, Dana-Farber Cancer Institute450 Brookline Ave, Boston MA 02215, USA
| | - Louise A Keogh
- Centre for Health Equity, The University of MelbourneParkville 3010, VIC, Australia
| |
Collapse
|
4
|
Hawke LD, Sheikhan NY, Jones N, Slade M, Soklaridis S, Wells S, Castle D. Embedding lived experience into mental health academic research organizations: Critical reflections. Health Expect 2022; 25:2299-2305. [PMID: 35999670 PMCID: PMC9615091 DOI: 10.1111/hex.13586] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 07/26/2022] [Accepted: 08/10/2022] [Indexed: 11/29/2022] Open
Abstract
Background As part of a growing emphasis on engaging people with lived experience of mental health conditions in mental health research, there are increasing calls to consider and embed lived experience throughout academic research institutes. This extends beyond the engagement of lay patients and also considers the potential roles of academic researchers with lived experience. When the lived experience of academic researchers is applied to academic work, there is the potential to improve the relevance of the research, while destigmatizing mental illness within academia. However, there are different and often contrasting perspectives on the way a lived experience academic researcher initiative should be implemented. Objectives This article describes some of the key issues to be considered when planning an initiative that leverages and values the lived experience of academic researchers, including the advantages and disadvantages of each potential approach. Discussion & Recommendations Institutions are encouraged to reflect on the ways that they might support and value lived experience among academic researchers. In developing any such initiative, institutions are encouraged to be transparent about their objectives and values, undertake a careful planning process, involve researchers with lived experience from the outset and consistently challenge the stigma experienced by academic researchers with lived experience. Patient or Public Contribution Multiple authors are academic researchers with lived experience of mental health conditions.
Collapse
Affiliation(s)
- Lisa D Hawke
- Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.,Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
| | - Natasha Y Sheikhan
- Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.,Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Nev Jones
- School of Social Work, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Mike Slade
- School of Health Sciences, University of Nottingham, Nottingham, UK.,Faculty of Medicine & Health Sciences, Nord University, Namsos, Norway
| | - Sophie Soklaridis
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.,Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.,Education Services, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Samantha Wells
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.,Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - David Castle
- Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.,Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|